Nexalin Technology (NASDAQ:NXL – Get Free Report) and Diadexus (OTCMKTS:DDXS – Get Free Report) are both small-cap healthcare companies, but which is the superior business? Valuation and EarningsThis table compares Nexalin Technology and Diadexus”s top-line revenue, earnings per share and valuation. Get Nexalin Technology alerts:Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Nexalin Technology $300,000.00 25.60 -$8.22 million ($0.47) -0.74 Diadexus N/A N/A N/A N/A N/AProfitabilityDiadexus has lower revenue, but higher earnings than Nexalin Technology. Net Margins Return on Equity Return on Assets Nexalin Technology -3,018.12% -191.88% -166.43% Diadexus N/A N/A N/AAnalyst RecommendationsThis is a summary of recent ratings and target prices for Nexalin Technology and Diadexus, as reported by MarketBeat. Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nexalin Technology 1 0 0 0 1.00 Diadexus 0 0 0 0 0.00Given Diadexus’ higher possible upside, analysts clearly believe Diadexus is more favorable than Nexalin Technology.